847 related articles for article (PubMed ID: 20236142)
1. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
Bellingham MC
CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
[TBL] [Abstract][Full Text] [Related]
2. Riluzole: what it does to spinal and brainstem neurons and how it does it.
Cifra A; Mazzone GL; Nistri A
Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264
[TBL] [Abstract][Full Text] [Related]
3. Riluzole for the treatment of amyotrophic lateral sclerosis.
Saitoh Y; Takahashi Y
Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
[TBL] [Abstract][Full Text] [Related]
4. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
Cheah BC; Vucic S; Krishnan AV; Kiernan MC
Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
[TBL] [Abstract][Full Text] [Related]
5. Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
Cifra A; Nani F; Nistri A
Eur J Neurosci; 2011 Mar; 33(5):899-913. PubMed ID: 21324003
[TBL] [Abstract][Full Text] [Related]
6. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
[TBL] [Abstract][Full Text] [Related]
7. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Cochrane Database Syst Rev; 2007 Jan; (1):CD001447. PubMed ID: 17253460
[TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis, excitotoxicity and riluzole.
Obrenovitch TP
Trends Pharmacol Sci; 1998 Jan; 19(1):9-11. PubMed ID: 9509893
[No Abstract] [Full Text] [Related]
9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Moore DH
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD001447. PubMed ID: 22419278
[TBL] [Abstract][Full Text] [Related]
10. Pre- and postsynaptic mechanisms underlying inhibition of hypoglossal motor neuron excitability by riluzole.
Bellingham MC
J Neurophysiol; 2013 Sep; 110(5):1047-61. PubMed ID: 23741042
[TBL] [Abstract][Full Text] [Related]
11. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
12. Riluzole has no acute effect on motor unit parameters in ALS.
Desai J; Sharief M; Swash M
J Neurol Sci; 1998 Oct; 160 Suppl 1():S69-72. PubMed ID: 9851653
[TBL] [Abstract][Full Text] [Related]
13. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
[TBL] [Abstract][Full Text] [Related]
14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Moore DH
Cochrane Database Syst Rev; 2001; (4):CD001447. PubMed ID: 11687111
[TBL] [Abstract][Full Text] [Related]
15. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
Noto Y; Shibuya K; Vucic S; Kiernan MC
Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
[TBL] [Abstract][Full Text] [Related]
16. Riluzole for amyotrophic lateral sclerosis.
Drug Ther Bull; 1997 Feb; 35(2):11-2. PubMed ID: 9282413
[TBL] [Abstract][Full Text] [Related]
17. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
[TBL] [Abstract][Full Text] [Related]
18. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
[TBL] [Abstract][Full Text] [Related]
19. Riluzole does not have an acute effect on motor thresholds and the intracortical excitability in amyotrophic lateral sclerosis.
Sommer M; Tergau F; Wischer S; Reimers CD; Beuche W; Paulus W
J Neurol; 1999 Nov; 246 Suppl 3():III22-6. PubMed ID: 10631657
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.
Moujalled D; White AR
CNS Drugs; 2016 Mar; 30(3):227-43. PubMed ID: 26895253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]